Entero launches 'HealthEdge' programme to empower Retail Chemists

Entero Healthcare Solutions Limited, one of India's leading and fastest-growing healthcare product distribution platform, has launched its 'HealthEdge' programme for retail chemists. In line with this, Entero has acquired the tech-driven Aayu Chemist app and Medcords platform from Medcords Healthcare Solutions. This strategic move accelerates the digital transformation of retail chemists, equipping them with cutting-edge tools to enhance business efficiency, profitability, customer engagement and better purchase experience.

With a current network of 86,000+ retail chemists, Entero aims to deepen its chemist engagement. The acquisition of Aayu Chemist and Medcords aligns with Entero's commitment to integrating technology and healthcare distribution to drive sustained business growth.

Commenting on this development, Mr. Prabhat Agrawal, MD & CEO of Entero Healthcare, said, "The HealthEdge programme aligns perfectly with our vision to be a growth catalyst for retail chemists. Through this digital enablement, we empower chemists to stay ahead of the curve, ensuring their businesses are resilient and primed for significant growth. Retail chemists are invited to become part of the 'HealthEdge' ecosystem, and together, we will shape a future where technology and healthcare distribution work handin-hand to unlock new levels of success."

Shreyans, Co-Founder of Aayu Chemist by MedCords, added, "Quick commerce, with its focus on rapid delivery of everyday essentials, is impacting kirana and chemist shops in India by attracting customers seeking convenience, leading to a shift in consumer spending and potentially impacting the livelihoods of small business owners. Our journey with MedCords has always centred around empowering retail chemists, the backbone of India's healthcare system. Partnering with Entero amplifies this mission, bringing our technology and expertise to a broader network, ensuring lakhs of chemists benefit from future-ready solutions."

Transformative Features and Benefits of the 'HealthEdge' Programme

- Superfast Medicine Supply and Inventory Management - Increasing customer fill rate, Optimized logistics, ensuring seamless stock availability.

- Transparent Expiry Management and Auto-Refill Systems - Reducing sales and inventory losses for chemists.

- Exclusive Access to New Products and High-Margin Deals - Enhancing profitability.

- Seamless Online Store Management - Personalized website and app, plus ABHAenabled pharmacy recognition for a competitive edge.

- Customer Retention Tools - Medicine reminders, loyalty programs, and digital payment solutions to foster stronger customer relationships.

- Access to Healthcare Services - Offering doctor consultations and lab test bookings for a holistic customer experience.

- Financial Support - Credit facilities to retail chemists under this initiative, providing financial flexibility and stability.

- Integration with the Government's Digital Health Incentive Scheme - Enhancing operational efficiency and incentives for participants.

Entero Healthcare has witnessed strong performance in Q3FY25 with 37% revenue growth and 322% PAT growth over previous year.

Shares of Entero Healthcare Solutions Limited was last trading in BSE at Rs. 1154.70 as compared to the previous close of Rs. 1142.85. The total number of shares traded during the day was 2898 in over 422 trades.

The stock hit an intraday high of Rs. 1189.30 and intraday low of 1140.95. The net turnover during the day was Rs. 3351876.00.

Source : Equity Bulls

Keywords

EnteroHealthcareSolutions INE010601016 PharmacyRetail HealthEdge RetailChemists